Medical Director of New Jersey Plastic Surgery.

1440 nm wavelength beneficial in laser-assisted lipolysis for fat-disruption and tissue tightening Cynosure, Inc . today announced the demonstration of a new study that demonstrates the scientific benefits of utilizing a 1440 nm wavelength in laser-assisted lipolysis to disrupt unwanted fat tissue and tighten pores and skin through tissue coagulation.D., Medical Director of New Jersey Plastic Surgery, is one of six Cynosure-related abstracts being provided this week at the 2010 American Society for Laser Medicine and Surgery Annual Meeting in Arizona.

The vaccine was administered at different dosages, with or without alum adjuvant. The principal immunologic end points were the proportions of subjects with a rise in the hemagglutination-inhibition titer by a factor of 4 or more on day 21 after the first dosage and on day 35 . The second dose was administered on time 21, after data for the primary end point have been collected. The primary safety end factors were the presence of any systemic reaction or injection-site reaction 21 days after the first dose and 14 days following the second dose. Vaccine The influenza A 2009 monovalent, split-virus vaccine was developed by Hualan Biological Bacterin Firm, and the seed virus was prepared from reassortant vaccine virus A/California/7/2009 NYMC X-179A , distributed by the Centers for Disease Control and Prevention in the United States.